1.50
Nexalin Technology Inc stock is traded at $1.50, with a volume of 301.62K.
It is down -1.96% in the last 24 hours and up +63.54% over the past month.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$1.53
Open:
$1.51
24h Volume:
301.62K
Relative Volume:
0.07
Market Cap:
$26.13M
Revenue:
$174.80K
Net Income/Loss:
$-8.85M
P/E Ratio:
-2.178
EPS:
-0.6887
Net Cash Flow:
$-4.37M
1W Performance:
+4.17%
1M Performance:
+63.54%
6M Performance:
-17.58%
1Y Performance:
-39.76%
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Compare NXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology Inc
|
1.50 | 27.83M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Nexalin Technology Inc Stock (NXL) Latest News
Will Nexalin Technology Inc. Equity Warrant stock benefit from automationEarnings Overview Report & Precise Trade Entry Recommendations - newser.com
What data driven models say about Nexalin Technology Inc.’s futureEarnings Trend Report & Growth Focused Stock Reports - newser.com
What momentum shifts mean for Nexalin Technology Inc.2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from AI adoptionDay Trade & AI Enhanced Trading Signals - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedPortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Momentum divergence signals in Nexalin Technology Inc. chartWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com
Is Nexalin Technology Inc. forming a bottoming basePortfolio Value Summary & Weekly Market Pulse Updates - newser.com
How Nexalin Technology Inc. stock compares to industry benchmarksJuly 2025 Selloffs & Verified Entry Point Detection - newser.com
Why Nexalin Technology Inc. stock is in analyst buy zoneJuly 2025 Chart Watch & Free Reliable Trade Execution Plans - newser.com
Can Nexalin Technology Inc. stock outperform in 2025 bull marketJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - newser.com
Is this a good reentry point in Nexalin Technology Inc.Trade Analysis Report & Weekly High Return Stock Forecasts - newser.com
Analyzing Nexalin Technology Inc. with multi timeframe charts2025 Technical Overview & Community Consensus Picks - newser.com
Can Nexalin Technology Inc. stock reach $100 price target2025 Earnings Surprises & AI Driven Price Predictions - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboards2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Will Nexalin Technology Inc. stock sustain high P E ratiosJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Statistical indicators supporting Nexalin Technology Inc.’s strength2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Is Nexalin Technology Inc. stock a buy for dividend growthStock Surge & Scalable Portfolio Growth Ideas - newser.com
Is a relief rally coming for Nexalin Technology Inc. Equity Warrant holders2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Is Nexalin Technology Inc. Equity Warrant stock bottoming out2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Historical volatility pattern of Nexalin Technology Inc. Equity Warrant visualized2025 Big Picture & Short-Term High Return Strategies - newser.com
How geopolitical tensions affect Nexalin Technology Inc. stockEarnings Growth Report & Safe Capital Growth Plans - newser.com
Regression analysis insights on Nexalin Technology Inc. performanceTrend Reversal & Verified Technical Signals - newser.com
What institutional flow reveals about Nexalin Technology Inc. Equity WarrantIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-11-01 03:03:09 - newser.com
Can momentum traders help lift Nexalin Technology Inc.Market Rally & Advanced Technical Signal Analysis - newser.com
Can Nexalin Technology Inc. stock attract ESG capital inflowsWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Tick level data insight on Nexalin Technology Inc. volatility2025 Buyback Activity & Expert Curated Trade Setup Alerts - newser.com
How high can Nexalin Technology Inc. stock go2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nexalin Technology Inc Stock (NXL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):